Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
R-Evolution Worldwide is a multidisciplinary non-profit research consortium focused on global health challenges in low and middle-income countries. It leads and participates in international collaborations targeting infectious diseases such as dengue, Zika, monkeypox, and neurocysticercosis. The NeuroSolve project has obtained clinical trial ethical approvals in Tanzania and Zambia. The company is active in EU-funded consortia addressing emerging public health threats.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on R-Evolution Worldwide.